Life ScienceCompany
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business Ownership
Who owns Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business is owned by Nuvo Pharmaceuticals. It was acquired on September 19, 2018.
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business Business Overview
Where is Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business headquartered?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business is headquartered in Milton, Ontario.
What is Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business’ revenue?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business disclosed revenue of 15M USD for 2014 and 12M USD for 2013.
How many employees does Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business have?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business has 40 employees.
What sector is Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business in?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business is a life science company.
When was Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business founded?
Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business was founded in 1978.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.